Cobalt Capital Management Inc. Invests $10.25 Million in Humana Inc. $HUM

Cobalt Capital Management Inc. purchased a new position in Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 40,000 shares of the insurance provider’s stock, valued at approximately $10,245,000. Humana accounts for approximately 4.5% of Cobalt Capital Management Inc.’s investment portfolio, making the stock its 9th largest holding.

Several other hedge funds have also recently modified their holdings of HUM. Revolve Wealth Partners LLC purchased a new stake in shares of Humana in the 4th quarter worth approximately $202,000. Woodline Partners LP lifted its position in shares of Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares during the period. Sivia Capital Partners LLC lifted its position in Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after acquiring an additional 452 shares during the last quarter. Cresset Asset Management LLC lifted its position in Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after acquiring an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd lifted its position in Humana by 58.5% during the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after acquiring an additional 879 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on HUM. Royal Bank Of Canada reissued a “sector perform” rating on shares of Humana in a research report on Monday, June 1st. Mizuho increased their target price on shares of Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Robert W. Baird decreased their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Weiss Ratings raised shares of Humana from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, June 12th. Finally, TD Cowen increased their target price on shares of Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus target price of $291.35.

Humana Trading Down 2.0%

Shares of Humana stock opened at $361.95 on Thursday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $380.86. The firm has a market capitalization of $43.46 billion, a price-to-earnings ratio of 38.71, a PEG ratio of 2.10 and a beta of 0.76. The firm’s 50 day simple moving average is $279.36 and its two-hundred day simple moving average is $239.95.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the prior year, the business posted $11.58 EPS. Humana’s revenue for the quarter was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts predict that Humana Inc. will post 9.04 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. Humana’s dividend payout ratio is presently 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.